These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6928747)

  • 1. Gilles de la Tourette syndrome: clinical and family study of 50 cases.
    Nee LE; Caine ED; Polinsky RJ; Eldridge R; Ebert MH
    Ann Neurol; 1980 Jan; 7(1):41-9. PubMed ID: 6928747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gilles de la Tourette syndrome in Papua New Guinea.
    Johnson FY
    P N G Med J; 1995 Jun; 38(2):127-32. PubMed ID: 9599974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
    Robertson MM; Cavanna AE
    Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Leckman JF; Cohen DJ
    Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Tourette syndrome with haloperidol: predictors of success.
    Schwabe MJ; Konkol RJ
    Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome.
    Seuchter SA; Hebebrand J; Klug B; Knapp M; Lehmkuhl G; Poustka F; Schmidt M; Remschmidt H; Baur MP
    Genet Epidemiol; 2000 Jan; 18(1):33-47. PubMed ID: 10603457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compulsive disorder and Gilles de la Tourette syndrome. On the differential diagnosis of organic and psychogenic compulsive symptoms].
    Müller N; Putz A; Straube A; Kathmann N
    Nervenarzt; 1995 May; 66(5):372-8. PubMed ID: 7609819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gilles de la Tourette syndrome: a 20-month study of the effects of stressful life events and haloperidol on symptom frequency.
    Surwillo WW; Shafii M; Barrett CL
    J Nerv Ment Dis; 1978 Nov; 166(11):812-6. PubMed ID: 281456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large Italian family with Gilles de la Tourette syndrome: clinical study and analysis of the SLITRK1 gene.
    Fabbrini G; Pasquini M; Aurilia C; Berardelli I; Breedveld G; Oostra BA; Bonifati V; Berardelli A
    Mov Disord; 2007 Nov; 22(15):2229-34. PubMed ID: 17712845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tourette syndrome and chronic tics in a sample of children and adolescents.
    Saccomani L; Fabiana V; Manuela B; Giambattista R
    Brain Dev; 2005 Aug; 27(5):349-52. PubMed ID: 16023550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gilles de la Tourette's syndrome (Maladia des tics)--successful treatment with haloperidol].
    Nishiura N; Hirota Y
    No To Shinkei; 1970 Aug; 22(8):931-6. PubMed ID: 5270859
    [No Abstract]   [Full Text] [Related]  

  • 14. Sleep in Gilles de la Tourette syndrome.
    Mendelson WB; Caine ED; Goyer P; Ebert M; Gillin JC
    Biol Psychiatry; 1980 Apr; 15(2):339-43. PubMed ID: 6932227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gilles de la tourette syndrome: clinical spectrum and management].
    Calderón González R; Calderón Sepúlveda RF
    Rev Neurol; 2003 Apr 1-15; 36(7):679-88. PubMed ID: 12666050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathological features of obsessive-compulsive disorder in an Italian family with Gilles de la Tourette syndrome not linked to the SLITRK1 gene.
    Pasquini M; Fabbrini G; Berardelli I; Bonifati V; Biondi M; Berardelli A
    Psychiatry Res; 2008 Oct; 161(1):109-11. PubMed ID: 18722020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical analysis of a large Dutch Gilles de la Tourette family.
    Verkerk AJ; Cath DC; van der Linde HC; Both J; Heutink P; Breedveld G; Aulchenko YS; Oostra BA
    Mol Psychiatry; 2006 Oct; 11(10):954-64. PubMed ID: 16894393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An objective evaluation of haloperidol in Gilles de la Tourette's syndrome.
    Ford CV; Gottlieb F
    Dis Nerv Syst; 1969 May; 30(5):328-32. PubMed ID: 4890446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.